insulin lispro-aabc 100 UNT/ML Injectable Solution
- RxCUI
- 2380231
- RxNorm name
- insulin lispro-aabc 100 UNT/ML Injectable Solution
- Display name
- insulin lispro-aabc 100 UNT/ML Injectable Solution
- Full name
- insulin lispro-aabc 100 UNT/ML Injectable Solution
- Term type
- SCD
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:20
Purple Book Biologic Products#
| BLA | Proprietary name | Proper name | License type | Status | Latest source |
|---|---|---|---|---|---|
| 761109 | Lyumjev | insulin lispro-aabc | 351(a) | Rx | 2026-07-01 |
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| LYUMJEV | INSULIN LISPRO-AABC | A-S Medication Solutions | 616daea1-0b79-4970-a141-6f99f2072f02 | 2026-04-13 | Warnings, Adverse reactions | 2380231 |
| LYUMJEV | INSULIN LISPRO-AABC | Eli Lilly and Company | c5a056e2-b568-4ca6-9ed8-79c010942d00 | 2025-12-30 | Warnings, Adverse reactions | 2380231 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| c5a056e2-b568-4ca6-9ed8-79c010942d00 | insulin lispro-aabc 100 UNT/ML Injectable Solution [PSN] · insulin lispro-aabc 100 UNT/ML Injectable Solution [SCD] | 2 | 11 | These highlights do not include all the information needed to use LYUMJEV safely and effectively. See full prescribing information for LYUMJEV. LYUMJEV (insulin lispro-aabc) injection, for subcutaneous or intravenous use Initial U.S. Approval: 2020 | 20251230 |
| 616daea1-0b79-4970-a141-6f99f2072f02 | insulin lispro-aabc 100 UNT/ML Injectable Solution [PSN] · insulin lispro-aabc 100 UNT/ML Injectable Solution [SCD] | 2 | 3 | These highlights do not include all the information needed to use LYUMJEV safely and effectively. See full prescribing information for LYUMJEV. LYUMJEV (insulin lispro-aabc) injection, for subcutaneous or intravenous use Initial U.S. Approval: 2020 | 20260413 |